One-year, randomized, open-label study comparing the safety and efficacy of lanthanum carbonate (Fosrenol®) and calcium carbonate in dialysis patients.

被引：0
|
作者：
Torres, A
De Broe, ME
D'Haese, PC
Hutchison, A
Jones, C
机构：
[1] Univ Canaries Hosp, Dept Nephrol, Tenerife, Spain
[2] Univ Antwerp, Dept Nephrol, B-2020 Antwerp, Belgium
[3] Manchester Royal Infirm, Inst Nephrol & Transplantat, Manchester M13 9WL, Lancs, England
[4] Shire Pharmaceut Grp Plc, Basingstoke, Hants, England
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：764A / 764A
页数：1
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF CALCIUM DOBESILATE IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY - AN OPEN-LABEL, MULTICENTER STUDY
    ANGEHRN, F
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (04): : 346 - 357
  • [42] Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label study
    Handley, Alison
    Lloyd, Eric
    Roberts, Andrew
    Barger, Bruce
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2016, 38 (02) : 180 - 188
  • [43] One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: Results of a multicenter, open-label study
    Rothner, AD
    Winner, P
    Nett, R
    Asgharnejad, M
    Laurenza, A
    Austin, R
    Peykamian, M
    CLINICAL THERAPEUTICS, 2000, 22 (12) : 1533 - +
  • [44] Sevelamer Versus Calcium Carbonate in Incident Hemodialysis Patients: Results of an Open-Label 24-Month Randomized Clinical Trial
    Di Iorio, Biagio
    Molony, Donald
    Bell, Cynthia
    Cucciniello, Emanuele
    Bellizzi, Vincenzo
    Russo, Domenico
    Bellasi, Antonio
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 62 (04) : 771 - 778
  • [45] Safety and effectiveness of lurasidone in adolescents with schizophrenia: A one-year interim analysis of a 2-year open-label extension study
    Correll, C.
    Tocco, M.
    Goldman, R.
    Pikalov, A.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S127 - S127
  • [46] Reducing high phosphate levels in patients with chronic renal failure undergoing dialysis: a 4-week, dose-finding, open-label study with lanthanum carbonate
    Hutchison, AJ
    Speake, M
    Al-Baaj, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (07) : 1902 - 1906
  • [47] Efficacy of a moisturizer for pruritus accompanied by xerosis in patients undergoing dialysis: A multicenter, open-label, randomized verification study
    Yoshida, Yukie
    Hirama, Akio
    Hashimoto, Kazumasa
    Sato, Takeshi
    Yokota, Noritsugu
    Saeki, Hidehisa
    Kishida, Momoyo
    Nakamura, Hiroshi
    Kanakubo, Akira
    Tsuruoka, Shuichi
    JOURNAL OF DERMATOLOGY, 2021, 48 (09): : 1327 - 1335
  • [48] Efficacy and safety of lanthanum carbonate on chronic kidney disease–mineral and bone disorder in dialysis patients: a systematic review
    Chenglong Zhang
    Ji Wen
    Zi Li
    Junming Fan
    BMC Nephrology, 14
  • [49] Randomized crossover study comparing the phosphate-binding efficacy of calcium ketoglutarate versus calcium carbonate in patients on chronic hemodialysis
    Bro, S
    Rasmussen, RA
    Handberg, J
    Olgaard, K
    Feldt-Rasmussen, B
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (02) : 257 - 262
  • [50] One-year open-label study of the cognitive efficacy of blonanserin in antipsychotic-naive first-episode schizophrenia
    Miyamoto, S.
    Tenjin, T.
    Miyake, N.
    Ojima, K.
    Ninomiya, Y.
    Kitajima, R.
    Ogino, S.
    Kaneda, Y.
    Sumiyoshi, T.
    Yamaguchi, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 57 - 58
12345